
News|Articles|August 2, 2010
Formulary Digital Edition, August 2010
Disease-modifying therapy in adult relapsing-remitting multiple sclerosis; Focus on fingolimod; Agents in late-stage development for the management of weight
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FAQ: The uncertain future of enhanced ACA premium subsidies and what it means for U.S. healthcare
2
What UnitedHealth Group’s earnings call reveals about managed care trends
3
Could GLP-1s help with cognitive symptoms, pychosis of schizophrenia?
4
FDA approves combination therapy for blurry vision
5























